Aerie Pharmaceuticals reported $357.4M in Market Capitalization this June of 2022, considering the latest stock price and the number of outstanding shares.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Aerie Pharmaceuticals AERI:US $ 0.44B 0.11B
Alimera Sciences ALIM:US $ 0.04B 0B
Amarin AMRN:US 1.31B 0.03B
Antares Pharma ATRS:US $ 0.7B 0.09B
Bluebird Bio BLUE:US $ 0.35B 0.35B
Cara Therapeutics CARA:US $ 0.65B 0B
Coherus Biosciences CHRS:US $ 1B 0.23B
Endo International Ordinary Shares ENDP:US 0.54B 0.34B
Horizon Pharma HZNP:US 24.14B 0.3B
Insmed INSM:US $ 2.8B 0.44B
Merk MRK:US $ 207.45B 13.86B
Mirati Therapeutics MRTX:US $ 4.56B 3.54B
Novartis NOVN:VX 197.8B 2.36B
Ophthotech OPHT:US $ 1.95B 0.03B
Pacira Pharmaceuticals PCRX:US $ 3.42B 0.74B
Regeneron Pharmaceuticals REGN:US $ 75.81B 7.89B
Revance Therapeutics RVNC:US $ 1.4B 0.23B
Supernus Pharmaceuticals SUPN:US $ 1.72B 0.17B
Teva Pharmaceutical Industries TEVA:US 10.29B 0.72B
Valeant Pharmaceuticals VRX:CN C$ 10.14B 2.41B
Zoetis ZTS:US $ 88.87B 26.58B